A
Amelie Lier
Researcher at University Hospital Heidelberg
Publications - 16
Citations - 1970
Amelie Lier is an academic researcher from University Hospital Heidelberg. The author has contributed to research in topics: Haematopoiesis & Stem cell. The author has an hindex of 14, co-authored 16 publications receiving 1537 citations. Previous affiliations of Amelie Lier include German Cancer Research Center & Heidelberg University.
Papers
More filters
Journal ArticleDOI
Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells
Dagmar Walter,Amelie Lier,Anja Geiselhart,Frederic B. Thalheimer,Sina Huntscha,Mirko C. Sobotta,Bettina Moehrle,David Brocks,Irem Bayindir,Paul Kaschutnig,Katja Muedder,Corinna Klein,Anna Jauch,Timm Schroeder,Hartmut Geiger,Tobias P. Dick,Tim Holland-Letz,Peter Schmezer,Steven W. Lane,Michael A. Rieger,Marieke A.G. Essers,David A. Williams,Andreas Trumpp,Michael D. Milsom +23 more
TL;DR: This work shows in mice that DNA damage is a direct consequence of inducing HSCs to exit their homeostatic quiescent state in response to conditions that model physiological stress, such as infection or chronic blood loss, and provides a mechanistic explanation for the universal accumulation of DNA damage in H SCs during ageing and the accelerated failure of the haematopoietic system in Fanconi anaemia patients.
Journal ArticleDOI
Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis
Nina Cabezas-Wallscheid,Daniel Klimmeck,Daniel Klimmeck,Jenny Hansson,Daniel B. Lipka,Alejandro Reyes,Qi Wang,Dieter Weichenhan,Amelie Lier,Lisa von Paleske,Simon Renders,Peer Wünsche,Petra Zeisberger,David Brocks,Lei Gu,Lei Gu,Carl Herrmann,Simon Haas,Marieke A.G. Essers,Benedikt Brors,Roland Eils,Wolfgang Huber,Michael D. Milsom,Christoph Plass,Jeroen Krijgsveld,Andreas Trumpp +25 more
TL;DR: An unexpectedly dynamic pattern of transcript isoform regulation is found, suggesting a critical regulatory role during HSC differentiation, and a cell cycle/DNA repair signature associated with multipotency in MPP2 cells is found.
Journal ArticleDOI
Myelodysplastic Cells in Patients Reprogram Mesenchymal Stromal Cells to Establish a Transplantable Stem Cell Niche Disease Unit
Hind Medyouf,Maximilian Mossner,Johann Christoph Jann,Florian Nolte,Simon Raffel,Carl Herrmann,Amelie Lier,Christian Eisen,Verena Nowak,Bettina Zens,Katja Müdder,Corinna Klein,Julia Obländer,Stephanie Fey,Jovita Vogler,Alice Fabarius,Eva Riedl,Henning Roehl,Alexander Kohlmann,Marita Staller,Claudia Haferlach,Nadine Muller,Thilo John,Uwe Platzbecker,Georgia Metzgeroth,Wolf-Karsten Hofmann,Andreas Trumpp,Daniel Nowak +27 more
TL;DR: This patient-derived xenograft model provides functional and molecular evidence that MDS is a complex disease that involves both the hematopoietic and stromal compartments.
Journal ArticleDOI
Implementing tumor mutational burden (TMB) analysis in routine diagnostics—a primer for molecular pathologists and clinicians
Michael Allgäuer,Jan Budczies,Jan Budczies,Petros Christopoulos,Volker Endris,Amelie Lier,Eugen Rempel,Anna-Lena Volckmar,Martina Kirchner,Moritz von Winterfeld,Jonas Leichsenring,Olaf Neumann,Stefan Fröhling,Roland Penzel,Michael Thomas,Peter Schirmacher,Peter Schirmacher,Albrecht Stenzinger,Albrecht Stenzinger +18 more
TL;DR: An overview of the clinical implications of TMB testing is provided and key parameters including pre-analysis, analysis and post-analytical steps that influence and shape TMB approximation by panel sequencing are highlighted.
Journal ArticleDOI
Precision oncology based on omics data: The NCT Heidelberg experience.
Peter Horak,Barbara Klink,Christoph Heining,Stefan Gröschel,Barbara Hutter,Martina Fröhlich,Sebastian Uhrig,Daniel Hübschmann,Matthias Schlesner,Roland Eils,Daniela Richter,Katrin Pfütze,Christina Geörg,Bettina Meißburger,Stephan Wolf,Angela Schulz,Roland Penzel,Esther Herpel,Martina Kirchner,Amelie Lier,Volker Endris,Stephan Singer,Peter Schirmacher,Wilko Weichert,Albrecht Stenzinger,Richard F. Schlenk,Evelin Schröck,Benedikt Brors,Christof von Kalle,Hanno Glimm,Stefan Fröhling +30 more
TL;DR: MASTER (Molecularly Aided Stratification for Tumor Eradication Research), a clinically applicable platform for prospective, biology‐driven stratification of younger adults with advanced‐stage cancer across all histologies and patients with rare tumors is described.